Small biotechs fear US federal funding changes will harm innovation
This article was originally published in Scrip
Executive Summary
A plan to increase small business access to US government funds has met fierce opposition from some biotech and pharmaceutical companies, which are protesting that the changes to a research grant programme would "stifle innovation".